Names | |
---|---|
Preferred IUPAC name
2-{[(2H-1,3-Benzodioxol-5-yl)propan-2-yl]amino}ethan-1-ol | |
Other names
3,4-Methylenedioxy-N-hydroxyethylamphetamine 3,4-Methylenedioxy-1-(alpha-methylaminohydroxyethyl)ethane MDOHET, MDHET, MDHEA | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider | |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C12H17NO3 | |
Molar mass | 223.271 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
MDHOET, or 3,4-methylenedioxy-N-hydroxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-hydroxyethyl analogue of MDA. MDHOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg. MDHOET produces few to no effects. Very little data exists about the pharmacology, pharmacokinetics, effects, and toxicity of MDHOET.
Legality
United Kingdom
This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]
See also
References
- ↑ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
External links
- MDHOET entry in PiHKAL
- MDHOET entry in PiHKAL • info
- DEA reports about various MDHOET seizures in Europe and USA
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.